Simona Nedelcu
Overview
Explore the profile of Simona Nedelcu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dmytriw A, Ghozy S, Salim H, Musmar B, Siegler J, Kobeissi H, et al.
Radiology
. 2024 Aug;
312(2):e233041.
PMID: 39105645
Background The combination of intravenous thrombolysis (IVT) with mechanical thrombectomy (MT) may have clinical benefits for patients with medium vessel occlusion. Purpose To examine whether MT combined with IVT is...
2.
Kuhn A, Puri A, Salim H, Musmar B, Ghozy S, Siegler J, et al.
J Neurol
. 2024 Jul;
271(9):5853-5863.
PMID: 38967650
Background: While mechanical thrombectomy is considered standard of care for large vessel occlusions, scientific evidence to support treatment for distal and medium vessel occlusions remains scarce. Purpose: To evaluate feasibility,...
3.
Radu R, Costalat V, Romoli M, Musmar B, Siegler J, Ghozy S, et al.
Clin Neuroradiol
. 2024 Apr;
34(4):761-769.
PMID: 38687365
Background: Optimal anesthetic strategy for the endovascular treatment of stroke is still under debate. Despite scarce data concerning anesthetic management for medium and distal vessel occlusions (MeVOs) some centers empirically...
4.
Dmytriw A, Musmar B, Salim H, Ghozy S, Siegler J, Kobeissi H, et al.
Eur Stroke J
. 2024 Feb;
9(2):328-337.
PMID: 38409796
Background: Mechanical thrombectomy (MT) has revolutionized the treatment of acute ischemic stroke (AIS) due to large vessel occlusion (LVO), but its efficacy and safety in medium vessel occlusion (MeVO) remain...
5.
Wang M, Henkes H, Ghozy S, Siegler J, Shaikh H, Khalife J, et al.
Neuroradiology
. 2024 Feb;
66(4):631-641.
PMID: 38381145
Purpose: Our purpose was to assess the efficacy and safety of the pRESET LITE stent retriever (Phenox, Bochum, Germany), designed for medium vessel occlusion (MeVO) in acute ischemic stroke (AIS)...
6.
Nedelcu S, Gulati A, Henninger N
Interv Neuroradiol
. 2023 Dec;
:15910199231216510.
PMID: 38105534
Background: Distal and medium vessel occlusion (DMVO) strokes account for up to 40% of all acute ischemic strokes, many of which have a low initial deficit severity. Increasingly, endovascular treatment...
7.
Radu R, Costalat V, Fahed R, Ghozy S, Siegler J, Shaikh H, et al.
Eur Stroke J
. 2023 Oct;
9(1):114-123.
PMID: 37885243
Introduction: First pass effect (FPE), achievement of complete recanalization (mTICI 2c/3) with a single pass, is a significant predictor of favorable outcomes for endovascular treatment (EVT) in large vessel occlusion...
8.
Roy A, Sreekrishnan A, Camargo Faye E, Silverman S, Zachrison K, Harriott A, et al.
Neurol Clin Pract
. 2023 Oct;
13(6):e200209.
PMID: 37829551
Background And Objectives: Evaluation of transient ischemic attack/nondisabling ischemic strokes (TIA/NDS) in the emergency department (ED) contributes to capacity issues and increasing health care expenditures, especially high-cost duplicative imaging. Methods:...
9.
Prust M, Halm A, Nedelcu S, Nieves A, Dhand A
Neurohospitalist
. 2021 Apr;
11(1):18-24.
PMID: 33868552
Background And Purpose: Social networks influence human health and disease through direct biological and indirect psychosocial mechanisms. They have particular importance in neurologic disease because of support, information, and healthy...
10.
Hilgendorf K, Leshchiner E, Nedelcu S, Maynard M, Calo E, Ianari A, et al.
Genes Dev
. 2013 Apr;
27(9):1003-15.
PMID: 23618872
The retinoblastoma protein gene RB-1 is mutated in one-third of human tumors. Its protein product, pRB (retinoblastoma protein), functions as a transcriptional coregulator in many fundamental cellular processes. Here, we...